Breast Cancer BRAs Study (Breast Cancer Biomechanics of Radiotherapy And Surgery)

NCT ID: NCT07135960

Last Updated: 2025-08-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-06

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study, delivered by Portsmouth Hospitals University NHS Trust in conjunction with the Research Group in Breast Health at the University of Portsmouth \[1\], aims to assess whether it is possible to test breast biomechanics in women who have had surgery with or without radiotherapy for the treatment of breast cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Breast cancer is an increasingly common condition, affecting \>56,000 women a year in the UK. Surgery and radiotherapy are commonly used to treat breast cancer. Both these treatments can affect the structure and movement of the breast tissue, which is collectively called breast biomechanics. Breast biomechanics has been studied in healthy women and in female athletes, and across the menstrual cycle, menopause and pregnancy. Investigators know from this research that breast biomechanics can affect the type of bra support women need, which when optimised can improve comfort and quality of life as well as reduce the potential for tissue damage. However, breast biomechanics and associated breast garment support requirements (bra support) have not yet been significantly investigated in women undergoing breast cancer treatment.

Patients who would be eligible to participate in this study include women aged 18 or treated with surgery +/- radiotherapy for breast cancer that affects one of their breasts. Patients will be recruited from the Breast Unit at Queen Alexandra Hospital, Cosham. Participation in this study will involve attending the biomechanics testing laboratory at UoP after their surgery and/or after radiotherapy, and optionally before surgery too. 3D scans and sensors will be used to assess the structure and movement of the breast. Participants will be asked their views on the testing methods, as well as their bra requirements and exercise habits before and after breast cancer treatment. The information generated from this study could be used in the future to help design better bras for women treated for breast cancer. It could also help women make decisions about treatment based on evidence about how the breast is likely to move differently afterwards and improve satisfaction with treatment outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants with relevant condition

No interventions assigned to this group

Women aged 18 or treated with surgery +/- radiotherapy for breast cancer that affects one of their b

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female
* 18 years of age or above
* Early or locally advanced breast cancer classified as B5a or B5b (radical treatment intent)
* Unilateral breast cancer (contralateral breast used as control)
* Receiving or has received breast cancer surgery
* +/- Adjuvant radiotherapy
* Able to travel to the University of Portsmouth Breast biomechanics laboratory
* Participant has capacity to consent.

Exclusion Criteria

* Metastatic breast cancer diagnosis
* \< 2 weeks post-operative
* \< 4 weeks post-radiotherapy
* Active post-operative breast infection
* Requirement of ongoing breast dressings
* Previous breast surgery to contralateral breast
* Bilateral breast cancer
* Epilepsy (due to strobe on 3D scanner)
* Pregnancy or \<6 weeks post-partum
* Breastfeeding
* Rockwood Frailty score \>5 (or those unable to ambulate un-aided)
* Requiring interpreter.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Portsmouth

OTHER

Sponsor Role collaborator

Portsmouth Hospitals NHS Trust

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Edward St John

Role: PRINCIPAL_INVESTIGATOR

Portsmouth Hospitals University NHS Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen Alexandra Hospital

Portsmouth, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amy Huseyin

Role: CONTACT

02392 286000

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PHU/2024/32

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.